咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Variance in Clinical Profile a... 收藏

Variance in Clinical Profile and Use of Anticoagulants in Valvular and Non Valvular Atrial Fibrillation

Variance in Clinical Profile and Use of Anticoagulants in Valvular and Non Valvular Atrial Fibrillation

作     者:Smriti Shakya Arun Sayami Ratna Mani Gajurel Chandra Mani Poudel Hemant Shrestha Surya Devkota Sanjeev Thapa Rajaram Khanal Smriti Shakya;Arun Sayami;Ratna Mani Gajurel;Chandra Mani Poudel;Hemant Shrestha;Surya Devkota;Sanjeev Thapa;Rajaram Khanal

作者机构:Department of Cardiology Manmohan Cardiothoracic Vascular and Transplant Centre (MCVTC) Institute of Medicine TUTH Kathmandu Nepal 

出 版 物:《World Journal of Cardiovascular Diseases》 (心血管病(英文))

年 卷 期:2020年第10卷第7期

页      面:488-499页

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主  题:Atrial Fibrillation Clinical Profile Anticoagulation 

摘      要:Introduction: Atrial fibrillation is the most common cardiac arrhythmia encountered in clinical practice that affects morbidity and mortality to a large extent. This study was intended to determine various clinical profile and etiological factors in valvular and non-valvular atrial fibrillation and evaluate the usage of anticoagulants in them in the settings of developing nation like ours. Methods: A hospital based cross-sectional observational prospective study was conducted at Manmohan Cardiothoracic Vascular and Transplant Center, Institute of Medicine, Nepal for a period of sixteen months. All the patients with atrial fibrillation who were admitted in the cardiology department were included. The demographic profile, etiology, clinical features and the usage of anticoagulants were recorded. Results: A total of 175 patients with atrial fibrillation were enrolled in the study with 62% nonvalvular and 38% valvular cases. The overall mean age was 60 ± 16.79 years but among valvular atrial fibrillation, it was 47.9 ± 14.013 and among nonvalvular atrial fibrillation, it was 67.85 ± 13.507 years. Majority of patients were female (56%). Sixty percent were from outside Kathmandu valley. Rheumatic heart disease was the most common cause (38.9%) followed by dilated cardiomyopathy, systemic hypertension, degenerative valvular heart disease, coronary artery disease, etc. The most common presentation was dyspnea. About 79% of valvular and 17% of nonvalvular atrial fibrillation patients were using anticoagulants. Conclusion: Atrial fibrillation was common in young females and rheumatic heart disease was the leading cause. Ther

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分